The First People's Hospital of Changzhou
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1918-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.czfph.com/en
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
Phase 2
Not yet recruiting
- Conditions
- Renal Neoplasma
- Interventions
- Biological: IL-2/IFN-αBiological: DC-CIK
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 1200
- Registration Number
- NCT02487550
The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
Phase 2
Active, not recruiting
- Conditions
- Stomach Neoplasms
- Interventions
- Biological: Cytokine-Induced Killer Cells
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2016-02-19
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 80
- Registration Number
- NCT02485015
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Phase 2
Active, not recruiting
- Conditions
- Cholangiocarcinoma
- Interventions
- Procedure: Radiofrequency ablationBiological: Cytokine-induced killer cells
- First Posted Date
- 2015-06-26
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 50
- Registration Number
- NCT02482454
- Locations
- 🇨🇳
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: Hepatic RFAProcedure: Primary tumor resection
- First Posted Date
- 2015-06-19
- Last Posted Date
- 2015-06-19
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 78
- Registration Number
- NCT02475889
TOF Versus SOX in Metastatic Gastric Cancer
Phase 2
Completed
- Conditions
- Gastric Cancer
- Interventions
- Drug: oxaliplatin+S1Drug: paclitaxel+oxaliplatin+fluorouracil
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 60
- Registration Number
- NCT02442362
Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer
Phase 2
Completed
- Conditions
- Rectum Cancer
- Interventions
- Drug: Systemic chemotherapy (FOLFIRI)Procedure: Computed tomography guided radioactive seeds implant
- First Posted Date
- 2015-04-22
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 56
- Registration Number
- NCT02423226
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: Radiofrequency ablationBiological: Cytokine-induced killer cells
- First Posted Date
- 2015-04-17
- Last Posted Date
- 2015-04-17
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 60
- Registration Number
- NCT02419677
- Locations
- 🇨🇳
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath